Search results
5 Tips to Help Fight Stress
New Jersey Business Magazine· 4 days agoA recent Gallup Poll revealed that 55% of Americans said they experienced stress “a lot” during the day, up from 46% in 2006. In the workplace, stress...
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest...
WRBL Columbus· 7 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results ...
VueReal Unveils Groundbreaking MicroLED Innovations Across Auto, Consumer Electronics, and AR/VR at...
Digital Journal· 1 day ago...
Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management
Digital Journal· 1 day agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA) (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, announced today ...
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023
Digital Journal· 1 day ago...Poolbeg Pharma PLC Announces Appointment of Joint Broker Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate Trident Royalties PLC Announces Notice of Q1 2024 Activities Update Centamin PLC Announces Total Voting Rights...
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and...
WSYR 9 Syracuse· 6 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma -...
Benzinga· 1 day agoNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, announced today that the first patient in its Phase
Roquefort Therapeutics readies to partner after making significant pre-clinical headway
Proactive Investors· 5 days agoRoquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) said that significant preclinical progress has...
Newborn Screening Emergency: Urgent Call for Action to Identify 10,000+ Undiagnosed Rare Diseases
PRWeb· 2 days agoRecognizing these challenges, there is an urgent need for collaboration between the U.S., India, and...
Leading Tech Talent Marketplace hackajob Reacts to Changing Tech Landscape with Contract-based...
Digital Journal· 1 day ago...Poolbeg Pharma PLC Announces Appointment of Joint Broker Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate Trident Royalties PLC Announces Notice of Q1 2024 Activities Update Centamin PLC Announces Total Voting Rights...